Combination of epinastine, pseudoephedrine and methylephedrine as a new pharmacological formula

摘要

It refers to an oral pharmacological synthesis, including: (a) 2-25 mg epinasine; (b) 10-240 mg methylephedrine; (c) 10-300 mg pseudoephedrine; (d) a vehicle or precursor chemical acceptable without belladonna in the synthesis. This is a double-layer compression, in which layer a contains pseudoephedrine and methylephedrine that are released permanently, while layer B contains epinasmina that is released immediately, which is an effective method for treating cold, cough related symptoms, allergic reactions and / or other possible allergic diseases.